2022年

原著論文: 症例報告を含む

1.	Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T: Use of Systemic Corticosteroids for Reasons Other than Asthma in Subjects with Asthma. Respiration, 101: 109-115, 2022.
2.	Fukuda N, Horita N, Namkoong H, Kaneko A, Somekawa K, Tagami Y, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis. Thorac Cancer, 13: 84-94, 2022.
3.	Tateishi Y, Takeda A, Horita N: In Regard to Chang et al. Int J Radiat Oncol Biol Phys, 112: 574, 2022.
4.	Horita N, Kato H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic. Respirology, 27: 175-176, 2022.
5.	Matsumoto H, Kobayashi N, Somekawa K, Fukuda N, Kaneko A, Kamimaki C, Kubo S, Tanaka K, Tagami Y, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Koizumi H, Miura K, Miyazawa N, Kaneko T: Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial. Thorac Cancer, 13: 228-235, 2022.
6.	Chen H, Katakura S, Horita N, Namkoong H, Kato I, Hara Y, Kobayashi N, Fujii S, Kaneko T: Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy. Ther Adv Med Oncol, 14: 17588359211065152, 2022.
7.	Somekawa K, Horita N, Kaneko A, Tagami Y, Fukuda N, Matsumoto H, Namkoong H, Fujiwara Y, Minegishi K, Fukumoto T, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Adverse events induced by nivolumab and ipilimumab combination regimens. Ther Adv Med Oncol, 14: 17588359211058393, 2022.
8.	Adachi S, Oshikata C, Kaneko T, Tsurikisawa N: Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi. Allergy Asthma Clin Immunol, 18: 18, 2022.
9.	Hara Y, Oshima Y, Tagami Y, Aoki A, Fujii H, Izawa A, Seki K, Kanai A, Yabe A, Watanabe K, Horita N, Kobayashi N, Kaneko T: Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019. Respir Med Case Rep, 36:101615, 2022.
10.	Oshikata C, Zhu Y, Tanaka R, Kurihara Y, Kaneko T, Tsurikisawa N: Anaphylaxis caused by cross-reactivity of furocoumarins in lemon with orchardgrass. Ann Allergy Asthma Immunol , 128: 721-722, 2022.
11.	Nagano A, Takeuchi M, Horita N, Teshigawara T, Kawagoe T, Mizuki Y, Meguro A, Nakano H, Kirino Y, Takase-Minegishi K, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Kaneko T, Mizuki N: Behçet's disease and activities of daily living. Rheumatology(Oxford), 61: 1133-1140, 2022.
12.	Somekawa K, Horita N, Kaneko A, Tagami Y, Fukuda N, Matsumoto H, Namkoong H, Fujiwara Y, Minegishi K, Fukumoto T, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Adverse events induced by nivolumab and ipilimumab combination regimens. Ther Adv Med Oncol, 14: 17588359211058393, 2022.
13.	Hara Y, Tsukiji J, Yabe A, Onishi Y, Hirose H, Yamamoto M, Kudo M, Kaneko T, Ebina T: Heme oxygenase-1 as an important predictor of the severity of COVID-19. PLoS One, 17: e0273500, 2022.
14.	Teranishi S, Sugimoto C, Nagayama H, Segawa W, Miyasaka A, Hiro S, Maeda C, Tamura H, Masumoto N, Nagahara Y, Hirama N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma. Cancer Diagn Progn, 2: 253-257, 2022.
15.	Horita N, Kato H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Declined Mortality Due to Seasonal Influenza in Japan During the Coronavirus Disease 2019 Pandemic. Clin Infect Dis, 74: 2081, 2022.
16.	Kata Y, Hara Y, Tagami Y, Yabe A, Murohashi K, Nagasawa R, Nakashima K, Fujii H, Saigusa Y, Shiida M, Watanabe K, Horita N, Kobayashi N, Kaneko T: Assessment of diagnostic utility of serum hemeoxygenase-1 measurement for acute exacerbation of interstitial pneumonias. Sci Rep, 12: 12935, 2022.
17.	Mikami N, Takeda A, Hashimoto A, Takeda T, Kimura Y, Oku Y, Aoki Y, Eriguchi T, Tsurugai Y, Saeki N, Enomoto T, Kuribayashi H, Masuda M, Kaneko T: CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy. Clin Lung Cancer, 23: 428-437, 2022.
18.	Doshita K, Kenmotsu H, Omori S, Tabuchi Y, Kawabata T, Kodama H, Nishioka N, Miyawaki E, Iida Y, Miyawaki T, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Kaneko T, Takahashi T: Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis. Invest New Drugs, 40: 411-41, 2022.
19.	Oshikata C, Watanabe M, Hashimoto K, Yamazaki A, Kobayashi N, Konuma R, Ishida M, Kobayashi S, Shimada T, Kaneko T, Kamata Y, Kuriyama S, Kure S, Yanai M, Tsurikisawa N. Mite allergen avoidance decreases allergic symptoms in children in Ishinomaki city of Japan after natural disasters. Allergol Immunopathol (Madr), 50: 23-32, 2022.
20.	Miyakawa K, Kubo S, Stanleyraj Jeremiah S, Go H, Yamaoka Y, Ohtake N, Kato H, Ikeda S, Mihara T, Matsuba I, Sanno N, Miyakawa M, Shinkai M, Miyazaki T, Ogura T, Ito S, Kaneko T, Yamamoto K, Goto A, Ryo A: Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection. Open Forum Infect Dis, 9: ofab626, 2022.
21.	高橋 浩一郎, 小林 信明, 金子 猛: 呼吸器内科医の大学院進学とキャリア形成について, 日本呼吸器学会誌, 11: 128, 2022.

総説

1.	金子 猛: 【COPDと気管支喘息、その周辺疾患-病態・診断・治療の最新動向-】総論(COPDと気管支喘息)　咳嗽と喀痰から考えるCOPDと喘息. 日本臨床, 80: 21-26, 2022.
2.	金子 彩美, 小林 信明, 金子 猛: 臨床各科　難渋症例から学ぶ診療のエッセンス(File145)　免疫チェックポイント阻害薬による治療中に発症した肺結核. 日本医事新報, 5126: 12-13, 2022.
3.	田上 陽一, 原 悠, 金子 猛: 臨床各科　難渋症例から学ぶ診療のエッセンス(File 141)　ヘリコバクター・ピロリ除菌療法後に病変が消退した気管支原発MALTリンパ腫. 日本医事新報, 5120: 10-11, 2022.
4.	染川 弘平, 小林 信明, 金子 猛: 臨床各科　難渋症例から学ぶ診療のエッセンス(File 138)　新型コロナウイルスIgM抗体陽性で診断に苦慮した粟粒結核. 日本医事新報, 5116: 10-11, 2022.
5.	藤井 裕明, 原 悠, 金子 猛: 臨床各科　難渋症例から学ぶ診療のエッセンス(File 134)　抗ヒトIL-6レセプターモノクローナル抗体投与中のPasteurella multocidaによる膿胸. 日本医事新報, 5111: 10-11, 2022.
6.	渡邉 恵介, 原 悠, 金子 猛: 【重症気管支喘息治療のアップデート】合併症を有する気管支喘息　高齢者喘息. 呼吸器内科, 41, 55-60, 2022.
7.	原 悠, 金子 猛: 【喘息の発症メカニズムと治療・管理】診断と治療・管理　咳嗽と喀痰への対処. 医学のあゆみ, 281: 119-124, 2022.

学会発行診療ガイドライン等

1.	金子 猛(責任編集委員): 日本呼吸器学会『COPD診断と治療のためのガイドライン2022[第6版]』, メディカルレビュー社, 2022.
2.	金子 猛(作成委員): 日本喘息学会: 『喘息診療実践ガイドライン2022』, 協和企画, 2022.

著書

1.	金子 猛: ニューモシスチス肺炎. 今日の治療指針2022. 医学書院, 229-230, 2022.
2.	金子 猛: 咳嗽・喀痰, 日常診療に活かす 診療ガイドラインUP-TO-DATE 2022-2023, メディカルレビュー社, 81-86, 2022.
3.	金子 猛, 原 悠: 呼吸機能検査による評価, 内科学, 朝倉書店, Ⅱ342-Ⅱ347, 2022.

シンポジウム・教育講演等

1.	金子 猛: ＜特別講演＞「Unmet needs in airway mucus hypersecretion」. 日本呼吸器学会学術講演会, 京都, 2022, 4.
2.	金子 猛＜教育講演＞「ＣＯＰＤと呼吸器感染症」. 第70回日本化学療法学会総会, 愛知, 2022, 6.